BusinessDay (satire) (press release) (registration) (blog)Stem cell therapy: proffering hope for special needs patientsBusinessDay (satire) (press release) (registration) (blog)Hope is surely on the way for children with special needs as Alok Sharma, a… Continue reading
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
UC San Diego Health |
State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial
UC San Diego Health The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa … |
|
Global Cancer Gene Therapy Market 2017-2022: Expansion in Pharmaceutical Landscape & Growing Demand for …
Medgadget (blog) “Global Cancer Gene Therapy Market Professional Survey Report 2017-2022” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and … |
EurekAlert (press release) |
State’s stem cell agency awards $18.2 million grant for B cell cancer clinical trial
EurekAlert (press release) Kipps noted, too that cirmtuzumab targets cancer stem cells, which behave somewhat like the roots of the disease, resisting many forms of treatment and allowing a malignancy to grow back after apparently successful therapy. By targeting cancer stem … |